Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RSU saliva substitute is a topical medical device developed by Rangsit University (RSU) in Thailand for the symptomatic relief of xerostomia (dry mouth). Formulated as both a solution and a gel, the product is available in multiple flavors, including sweet mint, sweet vanilla, and lemon. It functions as a physical lubricant and moisturizer for the oral mucosa, mimicking the properties of natural saliva without containing a specific active pharmaceutical ingredient. Designed as a cost-effective alternative to commercial products like Biotene and GC Dry Mouth Gel, clinical trials have demonstrated its effectiveness in maintaining mucosal wetness and relieving dry mouth symptoms. The development of the formulation was supported by a grant from Rangsit University in 2022.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RSU saliva substitute.